Noticias diarias

The Gwangjin‑gu Pharmaceutical Association chaired by Han Eun‑kyung held its first joint meeting of branch heads and standing directors, reviewing response strategies for pharmacist duties, member rights, and plans for second‑half projects.

Albozen Korea supports employee‑run hobby clubs that also perform volunteer and environmental projects, enhancing internal communication and ESG management.

Dukem Bio signed a 34.3 billion KRW agreement to construct a radioactive‑pharmaceutical CDMO and R&D center in Jeongeup, aiming to create an East Asian hub by 2032.

GSK will pay $110 million upfront and could invest up to $1.295 billion to secure worldwide rights (excluding China, Hong Kong, Macau, Taiwan) to Hutchmed’s preclinical KRAS‑EGFR ADC, HMPL‑A830, slated for clinical trials later this year.

Pfizer handed over the CD228‑targeting ADC PF-08046031 to Medicus Pharma, receiving $12 million upfront and potential milestones exceeding $1 billion.

After a childcare hiatus, pharmacist Park Jeong‑bin’s ‘Secret Note’ column, popular on SNS as ‘Yakjumma’, will resume in the Korean Pharmacist Journal as Season 2 starting May 2026.

The Korean Pharmaceutical Policy Research Institute emphasizes patient‑centered care, noting its prominence at the ESMO Asia 2024 session for Asian patient groups.

The common cold often causes sore throat and fever; typical viruses include rhinovirus, coronavirus and adenovirus, with symptomatic treatment and rest recommended.

With registration for the 78th pharmacist national exam opening in a week, top scorer Jo Ho‑kyung, now a hospital pharmacist, shares his experience and encouragement with aspiring candidates.

The 2026 Pharmacy Growth Forum in Seoul highlighted consultation as a key competitive edge for dermacosmetics, with over 500 pharmacists discussing strategies and reviewing products from firms such as Dongguk Pharmaceutical, TruForm and ExoCobiotech.

The World Lung Cancer Congress 2026 will be held at COEX in Seoul Dec 12‑15, drawing 7,000+ experts from 100+ countries to discuss new lung‑cancer therapies.

The Korean Pharmacist Forum and the Pharmacist Literary Association have created a new platform for pharmacists to share poems and essays, blending professional life with literary expression.